Cargando…

Corrigendum: Structural basis for the broad and potent cross-reactivity of an N501Y-centric antibody against sarbecoviruses

Detalles Bibliográficos
Autores principales:	Jeong, Bo-Seong, Jeon, Joon Young, Lai, Chih-Jen, Yun, Hye-Yeoung, Jung, Jae U., Oh, Byung-Ha
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9773972/ https://www.ncbi.nlm.nih.gov/pubmed/36569833 http://dx.doi.org/10.3389/fimmu.2022.1103893

Ejemplares similares

Structural basis for the broad and potent cross-reactivity of an N501Y-centric antibody against sarbecoviruses
por: Jeong, Bo-Seong, et al.
Publicado: (2022)

Shark nanobodies with potent SARS-CoV-2 neutralizing activity and broad sarbecovirus reactivity
por: Chen, Wei-Hung, et al.
Publicado: (2023)

Structural basis for broad sarbecovirus neutralization by a human monoclonal antibody
por: Tortorici, M. Alejandra, et al.
Publicado: (2021)

Rational identification of potent and broad sarbecovirus-neutralizing antibody cocktails from SARS convalescents
por: Cao, Yunlong, et al.
Publicado: (2022)

Broad receptor tropism and immunogenicity of a clade 3 sarbecovirus
por: Lee, Jimin, et al.
Publicado: (2023)

Broad cross-reactivity across sarbecoviruses exhibited by a subset of COVID-19 donor-derived neutralizing antibodies
por: Jette, Claudia A., et al.
Publicado: (2021)

Broad cross-reactivity across sarbecoviruses exhibited by a subset of COVID-19 donor-derived neutralizing antibodies
por: Jette, Claudia A., et al.
Publicado: (2021)

Broad cross-reactivity across sarbecoviruses exhibited by a subset of COVID-19 donor-derived neutralizing antibodies
por: Jette, Claudia A., et al.
Publicado: (2021)

Elicitation of broadly protective sarbecovirus immunity by receptor-binding domain nanoparticle vaccines
por: Walls, Alexandra C., et al.
Publicado: (2021)

Elicitation of broadly protective sarbecovirus immunity by receptor-binding domain nanoparticle vaccines
por: Walls, Alexandra C., et al.
Publicado: (2021)

Antibody-mediated broad sarbecovirus neutralization through ACE2 molecular mimicry
por: Park, Young-Jun, et al.
Publicado: (2021)

An antibody class with a common CDRH3 motif broadly neutralizes sarbecoviruses
por: Liu, Lihong, et al.
Publicado: (2022)

Antibody-mediated broad sarbecovirus neutralization through ACE2 molecular mimicry
por: Park, Young-Jun, et al.
Publicado: (2022)

A broadly neutralizing nanobody targeting the highly conserved S2 subunit of sarbecoviruses
por: Wang, Xiaoyun, et al.
Publicado: (2023)

Broad Sarbecovirus Neutralizing Antibodies Obtained by Computational Design and Synthetic Library Screening
por: Yang, Xuehua, et al.
Publicado: (2023)

Structural basis for Sarbecovirus ORF6 mediated blockage of nucleocytoplasmic transport
por: Gao, Xiaopan, et al.
Publicado: (2022)

Superimmunity by pan-sarbecovirus nanobodies
por: Xiang, Yufei, et al.
Publicado: (2022)

Isolation of Bat Sarbecoviruses, Japan
por: Murakami, Shin, et al.
Publicado: (2022)

Broad sarbecovirus neutralizing antibodies define a key site of vulnerability on the SARS-CoV-2 spike protein
por: Wec, Anna Z., et al.
Publicado: (2020)

Broad Protection Against Clade 1 Sarbecoviruses After a Single Immunization with Cocktail Spike-Protein-Nanoparticle Vaccine
por: Halfmann, Peter J., et al.
Publicado: (2023)

A Multitrait Locus Regulates Sarbecovirus Pathogenesis
por: Schäfer, Alexandra, et al.
Publicado: (2022)

A comprehensive dataset of animal-associated sarbecoviruses
por: Liu, Bo, et al.
Publicado: (2023)

Cross-reactivity of eight SARS-CoV-2 variants rationally predicts immunogenicity clustering in sarbecoviruses
por: Li, Qianqian, et al.
Publicado: (2022)

Novel sarbecovirus bispecific neutralizing antibodies with exceptional breadth and potency against currently circulating SARS-CoV-2 variants and sarbecoviruses
por: Wang, Yingdan, et al.
Publicado: (2022)

Pan-sarbecovirus mAb protects from variants
por: Flemming, Alexandra
Publicado: (2021)

Novel attempts launched toward universal Sarbecovirus vaccine
por: Li, Haoyang, et al.
Publicado: (2021)

Genomic Bootstrap Barcodes and Their Application to Study the Evolution of Sarbecoviruses
por: Hassanin, Alexandre, et al.
Publicado: (2022)

ACE2 binding is an ancestral and evolvable trait of sarbecoviruses
por: Starr, Tyler N., et al.
Publicado: (2022)

Corrigendum: Characterization of SARS-CoV-2 Variants N501Y.V1 and N501Y.V2 Spike on Viral Infectivity
por: Tang, Haijun, et al.
Publicado: (2021)

Structural basis of sialidase in complex with geranylated flavonoids as potent natural inhibitors. Corrigendum
por: Lee, Youngjin, et al.
Publicado: (2015)

Preparing for R501
Publicado: (1977)

Structural and genetic basis for development of broadly neutralizing influenza antibodies
por: Lingwood, Daniel, et al.
Publicado: (2012)

Año 501 : la conquista continúa /
por: Chomsky, Noam
Publicado: (1993)

Humoral responses to the SARS-CoV-2 spike and receptor binding domain in context of pre-existing immunity confer broad sarbecovirus neutralization
por: Hauser, Blake M., et al.
Publicado: (2022)

Sarbecovirus ORF6 proteins hamper induction of interferon signaling
por: Kimura, Izumi, et al.
Publicado: (2021)

Neutralizing Antibody Response to Sarbecovirus Is Delayed in Sequential Heterologous Immunization
por: Lv, Huibin, et al.
Publicado: (2022)

Priming conditions shape breadth of neutralizing antibody responses to sarbecoviruses
por: Jia, Janice Zhirong, et al.
Publicado: (2022)

Vaccine-mediated protection against merbecovirus and sarbecovirus challenge in mice
por: Martinez, David R., et al.
Publicado: (2023)

A novel STING agonist-adjuvanted pan-sarbecovirus vaccine elicits potent and durable neutralizing antibody and T cell responses in mice, rabbits and NHPs
por: Liu, Zezhong, et al.
Publicado: (2022)

The basis of a more contagious 501Y.V1 variant of SARS-CoV-2
por: Liu, Haolin, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_kiimte9r048g2kjpbr2p0oftqc